| NRXPW Stock | | | USD 0.05 0 1.96% |
NRx Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating NRx Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NRx Pharmaceuticals is a good investment. Please check the relationship between NRx Pharmaceuticals Long Term Debt and its Other Current Assets accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRx Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy NRx Stock please use our
How to Invest in NRx Pharmaceuticals guide.
Long Term Debt vs Other Current Assets
Long Term Debt vs Other Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
NRx Pharmaceuticals Long Term Debt account and
Other Current Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between NRx Pharmaceuticals' Long Term Debt and Other Current Assets is 0.78. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of NRx Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of NRx Pharmaceuticals' Long Term Debt and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of NRx Pharmaceuticals are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Long Term Debt i.e., NRx Pharmaceuticals' Long Term Debt and Other Current Assets go up and down completely randomly.
Correlation Coefficient | 0.78 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Long Term Debt
Long-term debt is a debt that NRx Pharmaceuticals has held for over one year. Long-term debt appears on NRx Pharmaceuticals balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on NRx Pharmaceuticals balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Most indicators from NRx Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NRx Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRx Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy NRx Stock please use our
How to Invest in NRx Pharmaceuticals guide.
Selling General Administrative is likely to climb to about 28.2
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 8.9
M in 2024.
NRx Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
NRx Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NRx Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to
measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.